HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

McNeil Europe

Division of Johnson & Johnson

Latest From McNeil Europe

Regulatory News In Brief

FDA warns consumers of link between PPIs and clostridium difficile-associated diarrhea; FDA commissioner adopts transparency proposals; Wholistic Herbs herbal eye and nasal sprays on recall; more Regulatory News In Brief.

Consumer United States

Regulatory News In Brief

FDA warns consumers of link between PPIs and clostridium difficile-associated diarrhea; FDA commissioner adopts transparency proposals; Wholistic Herbs herbal eye and nasal sprays on recall; more Regulatory News In Brief.

Consumer United States

In Brief

GSK comments on nicotine’s status; Perrigo launches formula; NAI sales up with licensing revenue; Japanese star anise is adulterant; POMx for sale; toothpaste nurdle suit settled; Virility Max recalled

Consumer North America

Taking Zocor OTC in the UK: A Testing Ground for US Strategy?

The UK is set to become the first country in the world to see the launch of an OTC statin. In May 2004, UK regulators endorsed a switch application for Merck's once best-selling statin Zocor, genericized in 2003. Zocor Heart Pro will be targeted at an entirely different patient population to those currently on prescription statins. Tapping into this new market could in theory help Merck recoup some of the revenues it lost to generics in the prescription market. Yet the switch is perhaps less about generating small incremental UK revenues for Merck than about showing the FDA that making statins OTC is a viable and safe move.
BioPharmaceutical Consumer
See All

Company Information

UsernamePublicRestriction

Register